XML 25 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock, Common [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2021 $ 32,639 $ 6 $ 366 $ 293,030   $ (260,763)
Beginning Balance (in shares) at Dec. 31, 2021   565 36,574,702      
Issuance of common stock from stock option awards $ 22   $ 2 20    
Issuance of common stock from stock options awards, shares 339,125   242,475      
Issuance of restricted common stock $ 134   $ 1 133    
Issuance of restricted common stock, shares     115,000      
Stock-based compensation expense 406     406    
Repurchase of common stock (395)       $ (395)  
Repurchase of common stock, shares         243,468  
Net Income (Loss) 15,493         15,493
Ending Balance at Dec. 31, 2022 48,299 $ 6 $ 369 293,589 $ 395 (245,270)
Ending Balance (in shares) at Dec. 31, 2022   565 36,932,177   243,468  
Issuance of common stock from stock option awards $ 9   $ 1 8    
Issuance of common stock from stock options awards, shares 102,125   75,767      
Cumulative change in accounting principle $ (231)         (231)
Issuance of restricted common stock 151   $ 2 149    
Issuance of restricted common stock, shares     149,592      
Issuance of common stock due to conversion of Series N Preferred stock, shares   (2) 80      
Stock-based compensation expense 776     776    
Repurchase of common stock (399)       $ 399  
Repurchase of common stock, shares         152,707  
Net Income (Loss) 12,475         12,475
Ending Balance at Dec. 31, 2023 $ 61,080 $ 6 $ 372 $ 294,522 $ 794 $ (233,026)
Ending Balance (in shares) at Dec. 31, 2023   563 37,157,616   396,175